We are elated to announce our latest investment in SkyCell AG. SkyCell is transforming the pharmaceutical cold-chain logistics industry with its best-in-class hardware and software solutions. Leading global pharmaceutical companies are increasingly standardizing on SkyCell’s platform for not only its cold-chain excellence but also because it rapidly accelerates the achievement of their decarbonization goals. We are excited to partner with Richard Ettl, Nico Ros, Remo Gerber and the entire SkyCell AG team!
Exciting news! 🚀 SkyCell is thrilled to announce the closure of its US$116 million Series D funding round, with US$59 million coming from Tybourne Capital Management and CC Industries, Inc (CCI). This follows a US$57 million equity investment from Catalyst, M&G Investments’ purpose-led private assets strategy. The investment will fuel the continued expansion of SkyCell’s global footprint, focusing particularly on growth in the US and Asia. SkyCell’s Chief Financial Officer, Dr. Remo Gerber, commented, “Gaining CCI and Tybourne as investors significantly broadens our footprint in the US and Asia and is testament to our high growth based on strong financial fundamentals. Having established technological foundations in cold chain hardware, software, and IoT-enabled tracking, this investment enables us to commercialize our platform into adjacent pharma market segments, significantly expanding our total addressable market beyond cold chain packaging.” Read the full announcement below: https://lnkd.in/eKzBHHxV... #announcement #fundraising #investors #businessgrowth #Supplychain